Reference is made to the previous stock exchange announcement fromSoftOx Solutions AS (the "Company" or "SoftOx", ticker SOFTX) on4 January 2021 regarding the Company's extraordinary general meeting resolving tranche 2 in the previously announced private placement. The share capital increase pertaining to tranche 2 in the private placement ofNOK 8,181.80 divided on 409,090 shares has today been registered in theNorwegian Register ofBusiness Enterprises (Nw: Foretaksregisteret). Following the share capital increase, the new share capital in the Company isNOK 174,779.80 divided into 8,738,990 shares, each with a nominal value ofNOK 0.02 . The new shares will be listed and tradable on Euronext Growth Oslo from issuance in theCentral Securities Depository (VPS). For further information, please contact: Geir Almås, CEO ofSoftOx Solutions AS Mail: geir.almaas@soft-ox.com Mobile: +47 977 59 071 AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on the Oslo Stock Exchange Euronext Growth) is a Norwegian MedTech company based inOslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com
Click here for more information
© Oslo Bors ASA, source